home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
MOMA Therapeutics Appoints Peter Hammerman, M.D., Ph.D., as Chief Scientific Officer
MOMA Therapeutics Appoints Peter Hammerman, M.D., Ph.D., as Chief Scientific Officer
Post navigation
Previous Post
Previous
Revolution Medicines Highlights Slate of Diverse Board of Directors Nominees for Upcoming 2021 Annual Shareholder Meeting
Next Post
Next
Theseus Pharmaceuticals Appoints Tim Clackson, Ph.D., as Chief Executive Officer